AI Verdict
RUMBW has stronger fundamentals based on our AI analysis.
RVPH vs RUMBW Fundamental Comparison
| Metric | RVPH | RUMBW |
|---|---|---|
| Revenue | $122,867.0 | $100.6M |
| Net Income | $-19.9M | $-81.8M |
| Net Margin | -16,167.8% | -81.3% |
| ROE | -229.7% | -29.8% |
| ROA | -124.8% | -24.3% |
| Current Ratio | 2.08x | 5.84x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | N/A | $-0.32 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RVPH vs RUMBW: Frequently Asked Questions
Is RVPH or RUMBW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RUMBW has stronger fundamentals. RVPH is rated STRONG SELL (90% confidence) while RUMBW is rated SELL (78% confidence). This is not investment advice.
How does RVPH compare to RUMBW fundamentally?
REVIVA PHARMACEUTICALS HOLDINGS, INC. has ROE of -229.7% vs Rumble Inc.'s -29.8%. Net margins are -16,167.8% vs -81.3% respectively.
Which stock pays higher dividends, RVPH or RUMBW?
RVPH has a dividend yield of N/A or no dividend while RUMBW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RVPH or RUMBW for long term?
For long-term investing, consider that RVPH has STRONG SELL rating with 90% confidence, while RUMBW has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RVPH vs RUMBW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RVPH vs RUMBW, the AI consensus favors RUMBW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.